NZ712713A - Attenuated swine influenza vaccines and methods of making and use thereof - Google Patents

Attenuated swine influenza vaccines and methods of making and use thereof

Info

Publication number
NZ712713A
NZ712713A NZ712713A NZ71271313A NZ712713A NZ 712713 A NZ712713 A NZ 712713A NZ 712713 A NZ712713 A NZ 712713A NZ 71271313 A NZ71271313 A NZ 71271313A NZ 712713 A NZ712713 A NZ 712713A
Authority
NZ
New Zealand
Prior art keywords
swine influenza
strain
making
methods
attenuated
Prior art date
Application number
NZ712713A
Other languages
English (en)
Inventor
Benjamin M Hause
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of NZ712713A publication Critical patent/NZ712713A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NZ712713A 2012-07-17 2013-07-11 Attenuated swine influenza vaccines and methods of making and use thereof NZ712713A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261672398P 2012-07-17 2012-07-17
NZ704188A NZ704188A (en) 2012-07-17 2013-07-11 Attenuated swine influenza vaccines and methods of making and use thereof

Publications (1)

Publication Number Publication Date
NZ712713A true NZ712713A (en) 2017-05-26

Family

ID=48874529

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ712713A NZ712713A (en) 2012-07-17 2013-07-11 Attenuated swine influenza vaccines and methods of making and use thereof
NZ704188A NZ704188A (en) 2012-07-17 2013-07-11 Attenuated swine influenza vaccines and methods of making and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ704188A NZ704188A (en) 2012-07-17 2013-07-11 Attenuated swine influenza vaccines and methods of making and use thereof

Country Status (19)

Country Link
US (2) US9216211B2 (https=)
EP (1) EP2874656B1 (https=)
JP (1) JP6467672B2 (https=)
KR (1) KR102027758B1 (https=)
CN (1) CN104582725B (https=)
AU (2) AU2013290597B2 (https=)
BR (1) BR112015001020B1 (https=)
CA (1) CA2879228C (https=)
DK (1) DK2874656T3 (https=)
EA (1) EA033027B1 (https=)
ES (1) ES2662022T3 (https=)
HU (1) HUE036110T2 (https=)
MX (1) MX365880B (https=)
MY (1) MY166879A (https=)
NZ (2) NZ712713A (https=)
PH (1) PH12015500095A1 (https=)
PL (1) PL2874656T3 (https=)
PT (1) PT2874656T (https=)
WO (1) WO2014014726A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2874656T3 (pl) * 2012-07-17 2018-04-30 Merial, Inc. Atenuowane szczepionki przeciw grypie świń oraz ich sposoby wytwarzania i zastosowanie
JP6839714B2 (ja) * 2015-12-28 2021-03-10 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド M Hyo多重ワクチン及びその使用
EA201991319A1 (ru) * 2016-11-30 2019-11-29 Вакцины аттенуированного свиного гриппа и способы их изготовления и применения
CN106939355A (zh) * 2017-03-01 2017-07-11 苏州系统医学研究所 一种流感病毒弱毒活疫苗毒株的筛选和鉴定方法
CN107064499B (zh) * 2017-03-15 2019-06-18 青岛蔚蓝生物制品有限公司 禽流感病毒np蛋白抗原表位多肽及其胶体金试纸盒
JP2021508696A (ja) 2017-12-22 2021-03-11 コーダ−ジェニックス・インコーポレイテッドCoda−Genix, Inc. がん処置のためのコドン対脱最適化領域を有する組換え型ウイルス及びその使用法
CN112040977A (zh) 2018-03-08 2020-12-04 科达金尼克斯有限公司 减毒黄病毒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US5585250A (en) 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
ES2241042T3 (es) 1996-10-11 2005-10-16 The Regents Of The University Of California Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
KR20060026854A (ko) 2003-05-28 2006-03-24 위스콘신 얼럼나이 리서어치 화운데이션 PolⅡ 프로모터 및 리보자임을 갖는 재조합 인플루엔자벡터
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
CA2690196A1 (en) * 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
CA2716340A1 (en) 2008-02-21 2009-08-27 Biological Mimetics, Inc. Immunogenic influenza composition
CN102985107A (zh) 2010-01-24 2013-03-20 生物模仿公司 免疫性流感成分
PL2874656T3 (pl) * 2012-07-17 2018-04-30 Merial, Inc. Atenuowane szczepionki przeciw grypie świń oraz ich sposoby wytwarzania i zastosowanie

Also Published As

Publication number Publication date
CA2879228A1 (en) 2014-01-23
HK1209325A1 (en) 2016-04-01
PT2874656T (pt) 2018-03-09
EA201500140A1 (ru) 2016-02-29
KR20150036685A (ko) 2015-04-07
HUE036110T2 (hu) 2018-06-28
ES2662022T3 (es) 2018-04-05
US9216211B2 (en) 2015-12-22
BR112015001020B1 (pt) 2022-04-19
US9623105B2 (en) 2017-04-18
CA2879228C (en) 2021-07-13
BR112015001020A2 (https=) 2017-08-15
WO2014014726A1 (en) 2014-01-23
MX365880B (es) 2019-06-18
AU2016202693A1 (en) 2016-05-19
AU2016202693B2 (en) 2017-11-16
US20160120973A1 (en) 2016-05-05
DK2874656T3 (en) 2018-01-15
EA033027B1 (ru) 2019-08-30
AU2013290597B2 (en) 2016-02-04
PH12015500095B1 (en) 2015-03-02
JP2015524266A (ja) 2015-08-24
EP2874656A1 (en) 2015-05-27
KR102027758B1 (ko) 2019-10-02
NZ704188A (en) 2016-04-29
PL2874656T3 (pl) 2018-04-30
CN104582725B (zh) 2017-06-23
CN104582725A (zh) 2015-04-29
JP6467672B2 (ja) 2019-02-13
PH12015500095A1 (en) 2015-03-02
US20140023681A1 (en) 2014-01-23
MY166879A (en) 2018-07-24
AU2013290597A1 (en) 2015-02-19
EP2874656B1 (en) 2017-12-06
MX2015000713A (es) 2015-10-12

Similar Documents

Publication Publication Date Title
NZ712713A (en) Attenuated swine influenza vaccines and methods of making and use thereof
EA202090053A3 (ru) Способы и композиции для лечения неэффективного эритропоэза
BR112018070323A2 (pt) vacina contra rsv
MX2021010519A (es) Proteinas f de rsv de prefusion y su uso.
HK1225631A1 (zh) 免疫原性中东呼吸综合征冠状病毒(mers-cov)组合物和方法
NZ596366A (en) Enhanced immune response in avian species
MX342716B (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
EA201491754A1 (ru) Вакцина против rsv
NZ630869A (en) Compositions and methods for dengue virus chimeric constructs in vaccines
MY166282A (en) Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
WO2012054907A3 (en) Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
MX355501B (es) Estructuras de consenso de antigenos y vacunas elaboradas a partir de estas y metodos para utilizarlas en el tratamiento de la malaria.
MD20120127A2 (en) Recombinant Koi herpesvirus (KHV), method for its production and vaccine for the prevention of a disease caused by KHV
MX383416B (es) Nueva vacuna contra la influenza porcina.
NZ596501A (en) Casb7439 constructs
MY167069A (en) Antigen peptide and use thereof
DK201370530A (en) Salmonid alphavirus vaccine
PH12017502323B1 (en) Novel xylanase
WO2014153168A3 (en) Porcine astrovirus sequences and uses thereof
MX363264B (es) Vectores de vacuna recombinante de herpesvirus bovino 1 (bohv-1) con baja virulencia.
WO2014074817A3 (en) Attenuated mannheimia haemolytica vaccines and methods of making and use
MX2015009141A (es) Formulaciones de albu-bche, preparacion y usos de las mismas.
DK201370709A (en) Protein for use as a medicament
UA99801C2 (ru) Белковая конструкция, которая включает модифицированный полипептид casb7439

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: MERIAL, INC., US

Effective date: 20160107

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 JUL 2019 BY COMPUTER PACKAGES INC

Effective date: 20180703

ASS Change of ownership

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC., US

Effective date: 20190328

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 JUL 2020 BY COMPUTER PACKAGES INC

Effective date: 20190702

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 JUL 2021 BY COMPUTER PACKAGES INC

Effective date: 20200701

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 JUL 2022 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20210629

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 JUL 2023 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20220704

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 JUL 2024 BY DENNEMEYER + CO. SARL

Effective date: 20230703

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 JUL 2025 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20240702

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 JUL 2026 BY DENNEMEYER + CO. SARL

Effective date: 20250630